Motivate, Incentivize Your Team After the “Great Resignation”
Drug Topics
OCTOBER 3, 2022
It’s more important than ever to keep your team motivated and incentivized.
Mon.Oct 03, 2022
502 
The evolving roles and responsibilities of digital opinion leaders in medical education
PharmaVoice
OCTOBER 3, 2022
In the past, patients entrusted their healthcare providers to provide information about health-related matters.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Self-Management Education Key in Managing Hyperglycemia in Diabetes
Drug Topics
OCTOBER 3, 2022
Evidence suggests it improves outcomes and reduces hospitalizations.
Nobel Prize in medicine awarded for research into the evolutionary history of humankind
STAT
OCTOBER 3, 2022
A Swedish scientist won the 2022 Nobel Prize in medicine or physiology on Monday for his groundbreaking research into the evolutionary history of humankind. Svante Pääbo, of the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany, accomplished something widely believed to be impossible: recovering and reading DNA from 40,000-year-old bones.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
UAMS Wins NCPA 2022 Good Neighbor Pharmacy Pruitt-Schutte Student Business Plan Competition
Drug Topics
OCTOBER 3, 2022
The winner was announced during the first General Session of the 2022 NCPA Annual Convention.
IVIG Therapy May Fight Parvovirus-Associated Pure Red Cell Aplasia
Pharmacy Times
OCTOBER 3, 2022
Study results show that intravenous immunoglobulin therapy can help combat this type of PRCA in individuals with anemia.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Keytruda is the gift that keeps on giving for Merck, and here’s what’s next for the cancer juggernaut
PharmaVoice
OCTOBER 3, 2022
Long-term results showed five-year survival numbers for lung cancer patients that surpassed all others, and Merck's VP of oncology research tells us what he's excited about.
Expert: Point-of-Care Testing in Pharmacies is Valuable, Pertinent to Expectations of Patients
Pharmacy Times
OCTOBER 3, 2022
The value proposition for point-of-care testing in the pharmacy is extensive, as pharmacies can provide a convenient, accessible, and cost-saving alternative for patients.
Clinical trials haven’t harnessed the digital revolution — TransCelerate’s latest initiative aims to change that
PharmaVoice
OCTOBER 3, 2022
The nonprofit’s VP of portfolio management discussed its “most transformative” digital initiative to date.
FDA Grants Accelerated Approval to Futibatinib for Locally Advanced, Metastatic Cholangiocarcinoma
Pharmacy Times
OCTOBER 3, 2022
Futibatinib (Lytgobi, Taiho Oncology, Inc) is indicated for adult patients with previously treated, unresectable, locally advanced or metastatic intrahepatic cholangiocarcinoma harboring FGFR2 gene fusions or other rearrangements.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
To prevent unnecessary biopsies, scientists train an AI model to predict breast cancer risk from MRI scans
STAT
OCTOBER 3, 2022
A biopsy that turns out to have benign results can be a relief. But in some cases, it could also mean a patient whose risk of cancer was low from the start has gone through an unnecessarily invasive procedure. By and large, radiologists recommend that patients whose breast MRI scans raise suspicion of a cancerous growth get a biopsy done. But MRIs often pick up on benign lesions that other mammograms and ultrasound may not.
Pharmacy Students in Hawaii Hope to Use Culturally Competent Care in Their Future Careers
Pharmacy Times
OCTOBER 3, 2022
Thanks to its diverse patient population and unique culture, studying pharmacy in Hawaii provides interesting experiences with culturally competent care.
Hollywood and the Metaverse’s effect on pharma’s content
pharmaphorum
OCTOBER 3, 2022
Gaurav Kapoor, co-founder and executive vice president of Indegene, tells pharmaphorum how pharma can take lessons from the entertainment industry and prepare for the Metaverse to enhance content engagement. Pharma companies’ customer communication methods require reimagining as technology progresses. Kapoor says, now, pharma can learn from the on-demand nature of content distribution that Hollywood utilises and simultaneously prepare for future needs in content delivery. “One of our
BONUS: National Women Pharmacist Day, American Pharmacist Month
Pharmacy Times
OCTOBER 3, 2022
Women Pharmacist Day takes place October 12th, 2022.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Biogen agrees to pay $900 million in largest FCA Settlement Ever Secured without Government’s Intervention
The FDA Law Blog
OCTOBER 3, 2022
By Faraz Siddiqui & Jeffrey N. Wasserstein — On September 26, 2022, Biogen Inc. agreed to pay $900 million to the United States and various states to settle a False Claims Act (FCA) lawsuit. This lawsuit was brought to the U.S. district court of Massachusetts by former employee and whistleblower Michael Bawduniak in April 2012 as a qui tam action.
UK NICE recommends zanubrutinib for Waldenstrom’s macroglobulinaemia
Pharmaceutical Technology
OCTOBER 3, 2022
The UK National Institute for Health and Care Excellence (NICE) has recommended zanubrutinib (Brukinsa) as an option to treat Waldenstrom’s macroglobulinaemia (WM) patients. With the latest development, zanubrutinib became the first WM drug to receive the recommendation for routine National Health Service (NHS) usage in England. The recommendation will also be applicable in Wales and Northern Ireland.
Thrifty White Pharmacy receives URAC specialty pharmacy reaccreditation
Drug Store News
OCTOBER 3, 2022
By achieving this status, Thrifty White has demonstrated a comprehensive commitment to quality care, improved processes and better patient outcomes.
Harassment prompts children’s hospitals to strip websites, threatening access to gender-affirming care
STAT
OCTOBER 3, 2022
Children’s hospitals that have been targeted on social media for providing gender-affirming care — and even some that haven’t — are stripping information about those services from their websites. Advocates fear the changes could make it even harder for transgender adolescents to get care. Though the harassment has been most pronounced at Boston Children’s Hospital, right-wing pundits have singled out at least 20 other children’s hospitals on social media
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Real-time prescription benefit increases prescription pickup rates
Drug Store News
OCTOBER 3, 2022
Clinicians using Real-Time Prescription Benefit saw prescription pickup rates that were 3.2% points higher than those who did not use the service, according to a study by Surescripts.
Opinion: Better use of health savings accounts: lessons from Singapore
STAT
OCTOBER 3, 2022
Today, 9 in 10 Americans have health insurance, more than ever before, yet health care is less affordable than ever. Up to 100 million U.S. adults carry medical debt. Skyrocketing inflation is forcing people to decide between spending money on medical care or other necessities like food and housing. People typically spend thousands of dollars, in addition to premiums, before insurance kicks in.
Walgreens to reportedly use robots in pharmacy supply chain
Drug Store News
OCTOBER 3, 2022
Walgreens is opening new robotic fulfillment centers dedicated to packing prescription medications for pharmacy customers, according to a report.
White House’s open-access research directive scrambles long-entrenched models, raising key questions
STAT
OCTOBER 3, 2022
In August, the White House’s Office of Science and Technology Policy released a memo directing all federal agencies to form plans to make all federally funded research publications and data publicly available without embargo by the end of 2025. Most people who heard the news likely envisioned making a cup of coffee on Jan. 1, 2026, opening up JAMA’s or Nature’s website, and being able to read any article for free.
Zotos Professional’s Biotera launches revamped formulas
Drug Store News
OCTOBER 3, 2022
Available in Ultra Color Care and Ultra Moisturizing formulas, the products are made with pre- and post-biotic blends, as well as a signature beauty boosting botanical, the brand said.
5 Mistakes to Avoid When Buying Pharmacy Software
PioneerRx
OCTOBER 3, 2022
Picture long lines, wait times, and more stress than you can seem to manage. Your shoulders tense. Your head throbs. Your eyes watch the slow tick-tock.
Low-Priced Oncology Disruptors: The Cuckoo in the PD-1/PD-L1 Nest or the Runt of the Clutch?
pharmaphorum
OCTOBER 3, 2022
Part II. [NB: in Part I of this article, notions of lower-pricing intentionality and comparative global opportunities were explored. Now, in Part II, the authors look more closely at the practical affordability of implementation outside of the United States, weighing up the possibilities offered within Asia, Africa, and South America, as well as the power Europe and the UK yield in any potential outcome.].
Retailers begin offering support to communities impacted by hurricanes
Drug Store News
OCTOBER 3, 2022
Several retailers, including Walgreens, Southeastern Grocers, Publix, Hy-Vee and Walmart, are providing support to communities impacted by Hurricane Ian and Fiona.
Translarna not approved by NICE for DMD on NHS
pharmaphorum
OCTOBER 3, 2022
In draft guidance published on Friday, it emerged NICE does not recommend PTC Therapeutics’ Translarna (ataluren) for the treatment of Duchenne muscular dystrophy (DMD) caused by a nonsense mutation. The decision came following a re-evaluation of Translarna in order to decide whether to make it available for routine funding on the NHS. The re-evaluation followed a six-year period during which the DMD drug had been available under a managed access agreement (MAA), which ends in January next year,
STAT+: Many trials to confirm benefits of drugs granted accelerated approvals are running late
STAT
OCTOBER 3, 2022
Amid heightened debate over a regulatory program for speeding the approval of some medicines, a new government analysis finds extensive delays in the clinical trials that drug makers are required to conduct after approvals. At issue is accelerated approval, which the U.S. Food and Drug Administration established in 1982 in an effort to get medicines for hard-to-treat diseases to patients sooner than they might under the usual pathways to the marketplace.
Long-Term Care Makes Positive Impact for Older Individuals
Pharmacy Times
OCTOBER 3, 2022
Ronna Hauser, PharmD, and Bri Morris, PharmD, both from the National Community Pharmacists Association, discuss long-term care facilities and how they can make an impact on that patient population.
October is Breast Cancer Awareness Month
OctariusRx
OCTOBER 3, 2022
October is Breast Cancer Awareness Month and the OctariusRx team is spreading the word and supporting the cause by promoting the annual campaign to increase awareness of this disease. Do You Know Your Risk for Breast Cancer? There is no sure way to prevent breast cancer but getting regular screenings and being aware of risk factors is a great place to start.
Swimming algae microrobots deliver antibiotic nanoparticles to lungs
Outsourcing Pharma
OCTOBER 3, 2022
Researchers from the University of California San Diego tested whether algae could improve the delivery of antibiotics to treat cases of bacterial pneumonia.
Fremanezumab Found Effective for Migraines, Comorbid Anxiety and Depression
Pharmacy Times
OCTOBER 3, 2022
Teva Pharmaceutical Industries announced that fremanezumab can successfully reduce 2 common migraine comorbid symptoms—anxiety and depression.
LEO Pharma launches ‘AD Days Around the World’
Pharma Times
OCTOBER 3, 2022
Events will raise awareness around the impact of atopic dermatitis across cultures
Let's personalize your content